A Overview — StockExplainer

+147%

+9.4% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US

Exchange NYSE

Industry Medical - Diagnostics & Research

Sector Healthcare

Market Cap $39.14B

CEO Mr. Rodney Gonsalves

Agilent Technologies, Inc. is a company that makes tools and equipment used in science and healthcare. They create products that help scientists and doctors study living things, test for diseases, and analyze chemicals. Their offerings include machines that analyze DNA, liquids, and other samples, as well as software to help manage data. Agilent sells their products to labs and healthcare facilities around the world, helping improve research and diagnostics.

Streams of revenue

Cloud Services: 40%

Software Licensing: 24%

Consulting Services: 16%

Hardware Sales: 12%

Support Services: 8%

Estimations for reference only

Geographic Distribution

Americas: 38%

Europe: 31%

Asia-Pacific: 25%

Middle East & Africa: 6%

Estimations for reference only

Core Products

📊

SAP ERP Enterprise resource planning

☁️

AWS Cloud Cloud computing service

🖥️

Office 365 Productivity suite

🤝

Salesforce CRM Customer relationship manager

🔌

Cisco Networking Networking hardware

Business Type

Business to Business

Competitive Advantages

⭐

Strong Brand Reputation The company is recognized for reliability and quality in the healthcare and diagnostics sectors, fostering customer loyalty and trust.

🌐

Strong Distribution Network A robust global distribution and sales network ensures wide-reaching access to customers, improving market presence and sales efficiency.

🧪

Innovative Product Portfolio Agilent offers a diverse range of advanced analytical instruments and solutions tailored for life sciences and diagnostics, maintaining a technological edge.

⚙️

Comprehensive Service Offerings Agilent provides integrated services, including training and compliance support, enhancing customer experience and retention.

🔬

Extensive Research and Development Continuous investment in R&D enables Agilent to innovate and stay ahead of competitors, addressing emerging market needs effectively.

Key Business Risks

📉

Market Competition Intense competition in the diagnostics and life sciences market may lead to loss of market share.

🔒

Data Security Risks Risks associated with cybersecurity threats can compromise sensitive genetic and health data.

⚖️

Regulatory Compliance Non-compliance with healthcare regulations can lead to fines and operational disruptions.

🚚

Supply Chain Disruptions Dependence on global suppliers can lead to vulnerabilities in product availability and costs.

🛠️

Technological Obsolescence Rapid technological advancements can render existing products obsolete, impacting revenue.

Meeting Expectations

10 /10

Higher values indicate better execution and credibility

Business Overview

Performance Analysis

Stock Price

Performance Analysis

Stock Price